Pulse Biosciences Inc logo

Pulse Biosciences Inc

1
NAS:PLSE (USA)  
$ 13.76 -0.28 (-1.99%) 12:06 PM EST
At Loss
P/B:
21.17
Market Cap:
$ 772.78M
Enterprise V:
$ 762.52M
Volume:
60.69K
Avg Vol (2M):
236.21K
Also Trade In:
Volume:
60.69K
At Loss
Avg Vol (2M):
236.21K

Business Description

Description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
Name Current Vs Industry Vs History
Cash-To-Debt 3.92
Equity-to-Asset 0.74
Debt-to-Equity 0.25
Debt-to-EBITDA -0.21
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 63.25
9-Day RSI 64.13
14-Day RSI 64.64
6-1 Month Momentum % -18.85
12-1 Month Momentum % 6.89

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.06
Quick Ratio 7.06
Cash Ratio 6.87

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -29.2
Shareholder Yield % 7.3

Financials (Next Earnings Date:2024-08-09 Est.)

PLSE's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PLSE

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Pulse Biosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.796
Beta 1.97
Volatility % 135.52
14-Day RSI 64.64
14-Day ATR ($) 1.3787
20-Day SMA ($) 11.312379
12-1 Month Momentum % 6.89
52-Week Range ($) 3.716982 - 14.96
Shares Outstanding (Mil) 56.16

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pulse Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Pulse Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Pulse Biosciences Inc Frequently Asked Questions

What is Pulse Biosciences Inc(PLSE)'s stock price today?
The current price of PLSE is $13.76. The 52 week high of PLSE is $14.96 and 52 week low is $3.72.
When is next earnings date of Pulse Biosciences Inc(PLSE)?
The next earnings date of Pulse Biosciences Inc(PLSE) is 2024-08-09 Est..
Does Pulse Biosciences Inc(PLSE) pay dividends? If so, how much?
Pulse Biosciences Inc(PLSE) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1